The NF-κB pathway

The nuclear factor (NF)-κB transcription factor regulates expression of numerous components of the immune system ([Li and Verma, 2002][1]). These include proinflammatory cytokines, chemokines, adhesion molecules and inducible enzymes such as cycloxygenase-2 and inducible nitric oxide synthase,

[1]  René Bernards,et al.  Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB , 2003, Nature.

[2]  Genhong Cheng,et al.  The signaling adaptors and pathways activated by TNF superfamily. , 2003, Cytokine & growth factor reviews.

[3]  A. Bowie,et al.  The Toll-IL-1 receptor adaptor family grows to five members. , 2003, Trends in immunology.

[4]  B. Su,et al.  Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3 , 2004, Nature Immunology.

[5]  Michael Karin,et al.  NF-kappaB in cancer: from innocent bystander to major culprit. , 2002, Nature reviews. Cancer.

[6]  L. O’Neill.  TLRs: Professor Mechnikov, sit on your hat. , 2004, Trends in immunology.

[7]  E. Harhaj,et al.  NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. , 2001, Molecular cell.

[8]  C. Janeway,et al.  ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. , 1999, Genes & development.

[9]  M. Karin,et al.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. , 2001, Science.

[10]  G. Ghosh,et al.  KappaB-Ras binds to the unique insert within the ankyrin repeat domain of IkappaBbeta and regulates cytoplasmic retention of IkappaBbeta x NF-kappaB complexes. , 2003, The Journal of biological chemistry.

[11]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[12]  A. Ashworth,et al.  CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members , 2003, Nature.

[13]  R. Gaynor,et al.  IkappaB kinases: key regulators of the NF-kappaB pathway. , 2004, Trends in biochemical sciences.

[14]  H. Nakano,et al.  The atypical PKC‐interacting protein p62 channels NF‐κB activation by the IL‐1–TRAF6 pathway , 2000, The EMBO journal.

[15]  S. Ley,et al.  Functions of NF-?B1 and NF-?B2 in immune cell biology , 2004 .

[16]  S. Ghosh,et al.  PDK1 Nucleates T Cell Receptor-Induced Signaling Complex for NF-κB Activation , 2005, Science.

[17]  G. Courtois,et al.  The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination , 2003, Nature.

[18]  E. Harhaj,et al.  NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100 , 2001 .

[19]  Inder M Verma,et al.  NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.

[20]  Jae-Hyuck Shim,et al.  PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. , 2005, Science.

[21]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[22]  Zhijian J. Chen,et al.  Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.

[23]  W. Liao,et al.  The essential role of MEKK3 in TNF-induced NF-kappaB activation. , 2001, Nature immunology.

[24]  S. Janssens,et al.  A universal role for MyD88 in TLR/IL-1R-mediated signaling. , 2002, Trends in biochemical sciences.

[25]  B. Strahl,et al.  A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. , 2003, Nature.

[26]  S. Bacher,et al.  NF‐ĸB activation pathways induced by T cell costimulation , 2003 .

[27]  R. Gaynor,et al.  IκB kinases: key regulators of the NF-κB pathway , 2004 .

[28]  R. Gaynor,et al.  Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression , 2003, Nature.

[29]  B. Aggarwal,et al.  Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. , 2003, Biochemical pharmacology.

[30]  M. Schmitz,et al.  NF-kappaB: a multifaceted transcription factor regulated at several levels. , 2004, Chembiochem : a European journal of chemical biology.

[31]  W. Greene,et al.  Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation , 2003, Journal of Molecular Medicine.

[32]  D. Philpott,et al.  The role of Toll-like receptors and Nod proteins in bacterial infection. , 2004, Molecular immunology.

[33]  M. Schmitz,et al.  NF‐κB: A Multifaceted Transcription Factor Regulated at Several Levels , 2004 .

[34]  S. Ley,et al.  Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. , 2004, The Biochemical journal.

[35]  G. Bren,et al.  RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100* , 2002, The Journal of Biological Chemistry.

[36]  G. Ghosh,et al.  κB-Ras Binds to the Unique Insert within the Ankyrin Repeat Domain of IκBβ and Regulates Cytoplasmic Retention of IκBβ·NF-κB Complexes* , 2003, Journal of Biological Chemistry.

[37]  Brian D. Strahl,et al.  A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression , 2003, Nature.

[38]  Michael U. Martin,et al.  Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. , 2002, Biochimica et biophysica acta.

[39]  C. Scheidereit,et al.  The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators , 1999, Oncogene.

[40]  H. Young,et al.  BCL-3 and NF-κB p50 Attenuate Lipopolysaccharide-induced Inflammatory Responses in Macrophages* , 2004, Journal of Biological Chemistry.

[41]  D. Philpott,et al.  Innate immunity via Toll-like receptors and Nod proteins. , 2004, Current opinion in microbiology.

[42]  G. Ghosh,et al.  IkappaBbeta, but not IkappaBalpha, functions as a classical cytoplasmic inhibitor of NF-kappaB dimers by masking both NF-kappaB nuclear localization sequences in resting cells. , 2001, The Journal of biological chemistry.

[43]  Michael Karin,et al.  Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.

[44]  J. Ninomiya-Tsuji,et al.  The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway , 1999, Nature.

[45]  Zhijian J. Chen,et al.  TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. , 2004, Molecular cell.

[46]  S. Akira,et al.  Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. , 2004, Nature.

[47]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[48]  W. Liao,et al.  The essential role of MEKK3 in TNF-induced NF-κB activation , 2001, Nature Immunology.

[49]  Minoru Yoshida,et al.  A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/IκBα complexes , 2000 .

[50]  V. Bours,et al.  The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers , 1993, Cell.

[51]  J Louahed,et al.  Interleukin-9 regulates NF-kappaB activity through BCL3 gene induction. , 1999, Blood.

[52]  R. Gaynor,et al.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. , 2001, The Journal of clinical investigation.

[53]  A. Israël,et al.  T-cell-receptor- and B-cell-receptor-mediated activation of NF-κB in lymphocytes , 2004 .

[54]  S. Akira,et al.  Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ , 2004, Nature.

[55]  N. Kudo,et al.  A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Schmitz,et al.  NF-kappaB activation pathways induced by T cell costimulation. , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  Zhijian J. Chen,et al.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.